By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adaptive Biotechnologies 

307 Westlake Avenue N
Suite 300
Seattle  Washington  98109  U.S.A.
Phone: 206-659-0067 Fax: 206-659-0667



Company News
Adaptive Biotech And Collaborators Demonstrate Importance Of Minimal Residual Disease Measurement In Response Evaluation For Multiple Myeloma 7/15/2015 9:49:53 AM
Seattleā€™s Adaptive Biotech Will Set Up Shop in New York 7/1/2015 6:29:07 AM
Adaptive Biotech To Present Data From Largest Study To Date Demonstrating Superior Sensitivity And Prognostic Value Of Next-Generation Sequencing-Based Minimal Residual Disease (MRD) Detection In Pediatric Acute Lymphoblastic Leukemia 6/12/2015 7:54:07 AM
Children's Oncology Group/Pediatric Blood And Marrow Transplant Consortium Study Shows Adaptive Biotech' clonoSEQ Minimal Residual Disease (MRD) Test Superior To Flow Cytometry In Predicting Post-Transplant Relapse And Survival In Acute Lymphoblastic Leukemia 6/4/2015 7:26:09 AM
Here's What Juno Therapeutics (JUNO) Really Thinks About Local Rival Adaptive Biotech 5/29/2015 7:38:59 AM
ASCO15: Adaptive Biotech And Collaborators To Present Eight Studies At The 2015 American Society Of Clinical Oncology Annual Meeting Demonstrating The Relevance Of Monitoring Immune Receptors As A New Class Of Biomarkers 5/29/2015 7:19:27 AM
Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees 5/21/2015 6:31:28 AM
Adaptive Biotech' immunoSEQ Assay Provides Groundbreaking Insight Into T-Cell Fate, Significantly Advancing Understanding Of Adaptive Immunity 5/12/2015 10:11:04 AM
Adaptive Biotech And Collaborators To Present 5 Studies Demonstrating Utility Of Immunosequencing To Determine T-Cell Function In Chronic And Infectious Diseases At The 2015 American Association Of Immunologists Annual Meeting 5/8/2015 11:26:33 AM
Adaptive Biotech Bags $195 Million In Largest Washington Fundraise This Year 5/6/2015 7:01:55 AM